Medacta International
CompanySwitzerland
Medacta International develops one asset, in human trials (Mpact 3D Metal Monolith in total hip arthroplasty). Mostly device; based in Switzerland.
- 1
- Asset
- Furthest stage
- Human trials
- 1
- Trial
- 1
- Signal
Pipeline
1Porous titanium hip cup promotes bone ingrowth and osseointegration for primary and secondary implant stability.
Human trials, Device, total hip arthroplasty
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals1